Skip to main content
  • Home
  • Affected by Cancer
  • Healthy living
  • Clinical best practice
  • Research & Data
  • Publications & Resources
  • About us
  • Publications & Resources
  • Publications & Resources
  • Shared follow-up care

More at Cancer Australia

Australian Government - Cancer Australia
Home

CANCER AUSTRALIA STATEMENTS

  • Home
  • Breast cancer
  • Metastatic breast cancer

Practice 9

  • Home
  • Home
  • About the Statement
  • How the Statement was developed
  • The 12 Practices
  • Consumer Fact Sheets
  • mobile menu
  • Home
  • Home
  • About the Statement
  • How the Statement was developed
  • The 12 Practices
  • Consumer Fact Sheets
  • Home
  • Breast cancer
  • Metastatic breast cancer
  • Home
  • Home
  • How the Statement was developed
  • The 10 practices
  • Consumer Fact Sheets
  • A|A

Practice 9

Not appropriate to routinely use extensive locoregional therapy in metastatic breast cancer patients with minimal symptoms attributable to the primary tumour.

Consumer Information

Context

Not appropriate to routinely use extensive locoregional therapy in metastatic breast cancer patients with minimal symptoms attributable to the primary tumour.

Value to patients

Not appropriate to routinely use extensive locoregional therapy in metastatic breast cancer patients with minimal symptoms attributable to the primary tumour.

Supporting evidence

Not appropriate to routinely use extensive locoregional therapy in metastatic breast cancer patients with minimal symptoms attributable to the primary tumour.

published: Wed, 25/09/2019 - 20:23
Previous Next
  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
Copyright © 2021 - Cancer Australia